Dexamethasone and COVID-19 appears to support your hypothesis, but I noticed this bit:
For hospitalised patients with COVID-19 who were well enough to breathe on their own, dexamethasone offered no benefit; in fact there is a possibility that the medicine could have worsened health outcomes for some of those patients.
Patients in NOXCOVID-1 will be able to breathe on their own, so it looks like the experts who designed the trial are familiar with dexa and have factored its moa into the trial design.
- Forums
- ASX - By Stock
- NOXCOVID
NOX
noxopharm limited
Add to My Watchlist
2.04%
!
5.0¢

Dexamethasone and COVID-19 appears to support your hypothesis,...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
5.0¢ |
Change
0.001(2.04%) |
Mkt cap ! $14.61M |
Open | High | Low | Value | Volume |
5.0¢ | 5.1¢ | 5.0¢ | $14.75K | 295K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 763 | 5.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
5.1¢ | 49807 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 763 | 0.050 |
1 | 40000 | 0.049 |
1 | 300000 | 0.048 |
2 | 114034 | 0.047 |
1 | 50000 | 0.046 |
Price($) | Vol. | No. |
---|---|---|
0.051 | 49807 | 1 |
0.052 | 78600 | 1 |
0.054 | 38094 | 1 |
0.055 | 60000 | 1 |
0.056 | 20000 | 1 |
Last trade - 16.10pm 04/07/2025 (20 minute delay) ? |
Featured News
NOX (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Dr Michael Thurn, CEO & MD
Dr Michael Thurn
CEO & MD
SPONSORED BY The Market Online